Cargando…
Peptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Older Patients
Peptide drug Thymalin, isolated from the calve thymus, is successfully used for the treatment of various immunopathologies, including those in older age groups. The molecular mechanism of the Thymalin immunoprotective action is due to the effects of the short peptides KE, EW, EDP in its composition....
Autores principales: | Kuznik, B., Khavinson, V., Shapovalov, K., Linkova, N., Lukyanov, S., Smolyakov, Yu., Tereshkov, P., Shapovalov, Yu., Konnov, V., Tsybikov, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pleiades Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654498/ http://dx.doi.org/10.1134/S2079057021040068 |
Ejemplares similares
-
The Use of Thymalin for Immunocorrection and Molecular Aspects of Biological Activity
por: Khavinson, V. Kh., et al.
Publicado: (2021) -
The State of Microcirculatory Hemodynamics in Patients with Moderate and Severe COVID-19
por: Kuznik, B. I., et al.
Publicado: (2021) -
Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells
por: Khavinson, V. Kh., et al.
Publicado: (2020) -
The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19
por: Linkova, Natalia, et al.
Publicado: (2023) -
Peptides: Prospects for Use in the Treatment of COVID-19
por: Khavinson, Vladimir, et al.
Publicado: (2020)